Phenazopyridine Hydrochloride/Sulfamethoxazole/Trimethoprim

盐酸非那吡啶/磺胺甲噁唑/甲氧苄啶

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePhenazopyridine Hydrochloride/Sulfamethoxazole/Trimethoprim
Drug Alias Nameスルファメトキサゾール•トリメトプリムTrimethoprim/Sulfamethoxazole/Phenazopyridine HydrochlorideSulfamethoxazole and Trimethoprim and phenazopyridine hydrochloride
ClassificationSmall molecules
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsSodium channel alpha subunitDihydropteroate synthaseDihydrofolate reductase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsUrinary Tract Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2001/06/26
Country/TerritoryUnited States
CombinationsYes TrimethoprimPhenazopyridine HydrochlorideSulfamethoxazole
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAble Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAble Laboratories Inc
Active IndicationsN/A
Inactive IndicationsUrinary Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A